<DOC>
	<DOCNO>NCT02575885</DOCNO>
	<brief_summary>This randomize pilot clinical trial study nicotine delivery novel non-tobacco electronic system ( ENDS ) smoker . Studying level nicotine deliver various type brand ENDS bloodstream , compare level deliver conventional cigarette ( participant 's brand ) may help provide information use nicotine-containing product may help inform/reform current tobacco policy , practice , harm reduction approach .</brief_summary>
	<brief_title>Nicotine Delivery From Novel Non-Tobacco Electronic System Smokers</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine level nicotine effectively deliver various type brand ENDS bloodstream compare level deliver conventional cigarette . ( Study 1 ) II . Explore effect flavoring add nicotine solution puff topography nicotine delivery , ass compare short-term `` functional '' nicotine effect different product use subjective measure relief crave withdrawal symptom . ( Study 2 ) SECONDARY OBJECTIVES : I . Determine amount nicotine present various brand type ENDS . ( Study 3 ) II . Determine nicotine yield vapor various type ENDS laboratory condition . ( Study 4 ) TERTIARY OBJECTIVES : I . Develop standardized test protocol ENDS reflect user ' puff behavior product characteristic . II . Develop validate analytical method analysis nicotine content vapor . III . Propose standardize puff regimen generate vapor analytical purpose : Such test protocol reflect puff behavior observe among ENDS user specific ENDS type . OUTLINE : Participants randomize 1 2 arm . ARM I ( Study 1 ) : Participants ask smoke ad lib single cigarette brand provide different type ENDS product visit ( e-cigarette , disposable e-cigarette , eGo , personal vaporizer , e-cigar , e-pipe ) 3.5-4 hour least 7 day apart 7 week . Participants provide cartridge amount nicotine regular ( tobacco ) menthol flavor accord smoker 's preference , instruct use product , ask practice use 7 day , return study center next visit . ARM II ( Study 2 ) : Participants ask smoke ad lib single cigarette brand provide BLU e-cigarette ENDS product nicotine solution one five flavor 3.5-4 hour least 7 day apart 6 week . Participants provide cartridge maximum available amount nicotine different flavor visit , instruct use product , ask practice use 7 day , return study center next visit .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy basis medical history Current moderatetoheavy smoker determine : Has smoke 10 cigarette per day regularly past year ( history ) Has expire carbon monoxide ( CO ) screen visit 8 part per million ( ppm ) Nicotine dependence assess &gt; 4 Fagerstrom Test Nicotine Dependence Willingness abstain smoke 8 hour ( overnight abstinence ) prior study visit Participant legal representative must understand investigational nature study sign Independent Ethics Committee/Institutional Review Board approve write informed consent form prior receive study related procedure Unstable medical condition ( unstable heart disease , uncontrolled hypertension , thyroid disease , diabetes , renal liver impairment , glaucoma , prostatic hypertrophy ) psychiatric condition ( current major depression , history schizophrenia bipolar disorder , current regular use psychiatric medication major tranquilizer antidepressant Pregnancy lactation ( history ) positive pregnancy test screen visit Positive urine drug test screen visit History serious side effect nicotine nicotine replacement therapy Alcohol illicit drug dependence within past 12 month ( history urine test ) Concurrent participation another clinical trial Unable communicate English Unwilling unable follow protocol requirement Any condition Investigator 's opinion deem participant unsuitable candidate receive study intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>